HIGHLIGHTS
- who: Xiaoling Wu from the (UNIVERSITY) have published the Article: Description of CRISPR/Cas9 development and its prospect in hepatocellular carcinoma treatment, in the Journal: (JOURNAL)
- what: On the one hand, this experiment demonstrated hydrodynamic tail vein injection as a method for constructing liver cancer mouse model, and on the other, it created a new experimental scheme to verify specific gene function of liver cancer in animal model .
- how: Showed that CRISPR/Cas9 had higher efficiency in mutation of target gene . In the initial stage of the study researchers used sgRNAs sample bank . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.